2008 News about LifeVantage, Makers of Protandim and TrueScience

Wednesday, November 19, 2008 New Study Proves Protandim® Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor Results of a new peer-reviewed study published online in the journal Free Radical Biology and Medicine clearly demonstrates that the synergistic impact of the active ingredients used in the formulation of Protandim® dramatically increases the body's production of glutathione, a key antioxidant and anti-aging factor, as well as increases important antioxidant enzymes. more
Tuesday, November 18, 2008 LifeVantage Corporation Announces 1Q FY 2009 Financial and Operating Results LifeVantage Corporation (OTCBB: LFVN), maker of Protandim®, today announced results for its first quarter ended September 30, 2008. For the three month period ended September 30, 2008, the Company recorded net revenues of $1.3 million, which includes $0.5 million of previously deferred revenue, and a loss of $(0.1) million, or $(0.01) per share. For the three month period ended September 30, 2007, the Company recorded net revenues of $0.8 million and a loss of $(0.3) million, or $(0.01) per share. more
Wednesday, October 29, 2008 LifeVantage Announces Launch of Protandim(R) Into Multi-Billion Dollar Network Marketing Sales Channel Protandim® (www.Protandim.com), the only product clinically proven to slow the progressive rate of aging, announced today that it is entering the multi-billion dollar network marketing industry via independent distributorships offered by the product's maker, LifeVantage Corporation (OTCBB:LFVN). The company will continue to have a retail presence, in addition to the independent distributorships. more
Wednesday, October 08, 2008 Carlon M. Colker, M.D., FACN, Nationally Renowned Medical Expert in the Areas of Wellness, Physical Performance and Performance Nutrition, Joins LifeVantage Corporation Scientific Advisory Board LifeVantage Corporation (OTCBB:LFVN),the maker ofProtandim®, the only product clinically proven to slow the progressive rate of aging, today announced that nationally renowned wellness expert, Carlon Colker, M.D., FACN, has joined the Company's Scientific Advisory Board. Dr. Colker is the CEO and Medical Director of Peak Wellness, Inc., and is widely recognized as America's premier wellness advisor. He is well-known for his work with marquee athletes and for his many books and articles on various health and wellness issues. Dr. Colker is a regular medical correspondent on Fox News Channel and, as Shaquille O'Neal's physician, recently co-starred with O'Neal on ABC's "Shaq's Big Challenge", to fight childhood obesity. more
Wednesday, October 01, 2008 LifeVantage Corporation Schedules 4th Quarter and FY 2008 Conference Call SAN DIEGO--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB LFVN - News), maker of Protandim®, will hold a conference call on October 7, 2008 at 10:00 a.m. PT (1:00 p.m. ET) to discuss its fourth quarter and fiscal year 2008 financial and operating results. more
Tuesday, September 23, 2008 LifeVantage Corporation Announces Q4 and FY 2008 Financial and Operating Results SAN DIEGO--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB: LFVN- News), maker of Protandim®, today announced results for its year ended June 30, 2008. The Company recorded net revenues of $3.2 million and a net loss of $(2.1) million, or $(0.09) per share, for its year ended June 30, 2008. For its year ended June 30, 2007, the Company reported net revenues of $5.1 million and a net loss of $(3.7) million, or $(0.17) per share. more
Thursday, September 04, 2008 LifeVantage Corporation Invited to Present at EdgeWater Research Small/Micro Cap Conference September 24th and 25th, 2008 LifeVantage Corporation (OTCBB: LFVN), the maker ofProtandim®, the only product clinically proven to slow the progressive rate of aging, today announced that the senior management team has been invited to present at the upcoming EdgeWater Research Fall 2008 Small/Micro Cap Conference to be held in Coeur d' Alene, Idaho, on September 24th and 25th, 2008. more
Thursday, August 21, 2008 LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs LifeVantage Corporation(OTCBB:LFVN), the maker of Protandim®, the only product clinically proven to slow the progressive rate of aging, announced the company has joined forces with Cornerstone Research and Development, Inc., a leading manufacturer owned by Mitsui USA, to dramatically cut product manufacturing costs. more
Thursday, August 14, 2008 LifeVantage Corporation Posts Record Unique Visitors & Page Views for Protandim.com LifeVantage Corporation (OTCBB: LFVN),the maker of Protandim®, the only product clinically proven to slow the progressive rate of aging, announced today that Protandim.com had over 60,000 unique visitors to the website in July 2008, with over 170,000 page views, far exceeding historical levels. The company also reported that this increase in web traffic resulted in the highest number of new Internet customer acquisitions in nearly three years. more
Wednesday, August 13, 2008 LifeVantage Corporation Announces Increased Sales Distribution for Protandim(R) LifeVantage Corporation (OTCBB: LFVN) has announced it has increased distribution of Protandim® (www.protandim.com) via a network of well-known regional brokers; the initiation of a direct sales program to healthcare professionals; and a partnership providing an entree into the fitness arena. more
Wednesday, June 18, 2008 'Super-Antioxidant' Study to Examine Relationship between Anti-Aging and Skin's Natural Ability to Rejuvenate at the Cellular Level A new "Super-Antioxidant" study hopes to prove that the fountain of youth is on the horizon, thanks to advances in anti-aging that are attributed to regenerating skin at the cellular level. A team of researchers, led by Dr. Kimberly Stone, M.D., a leading Denver-based board certified dermatologist, are studying a blend of Protandim® (which has been clinically proven to slow the progressive rate of aging www.protandim.com) and LP Derma Complex (shown to effectively reduce the appearance of wrinkles and other effects of aging upon the skin) to determine if a topical cream made of these combined ingredients will play a pivotal role in providing proven methods to age gracefully. more
Monday, March 10, 2008 LifeVantage Expands Global Marketing Initiatives with the Addition of Key Industry Strategists Jan Strode and Peter Baloff LifeVantage Corporation (OTCBB: LFVN) announces that Jan Strode, prominent industry expert, advisor and strategist to companies ranging from start-ups to Fortune 100 companies on the topics of marketing, communications and sales, and Peter Baloff, nationally recognized creative consultant, have joined forces with LifeVantage, the maker of Protandim (www.protandim.com) to spearhead creative, marketing, and national public relations efforts. Protandim is the patented nutritional supplement that is clinically proven to slow the progressive rate of aging by increasing the body's natural antioxidant protection at the cellular level. more
Wednesday, March 05, 2008 LifeVantage Corporation Schedules 2nd Quarter FY 2008 Conference Call LifeVantage Corporation (OTCBB: LFVN), formerly Lifeline Therapeutics, Inc., maker of Protandim®, will hold a conference call on Tuesday, March 11, 2008 at 9:00 a.m. MT (11:00 a.m. ET) to introduce its new CEO David Brown, discuss its second quarter fiscal year 2008 financial and operating results, and remind investors of upcoming warrant expiration dates and repricing opportunities. Mr. Brown's presentation will be available on Monday, March 10, 2008 via the Company's website. more
Tuesday, February 19, 2008 Clinically Proven to Slow the Progressive Rate of Aging, Protandim(R), is Featured as a National Sponsor on PBS Series 'Healing Quest' Protandim(www.protandim.com) the patented nutritional supplement which is clinically proven to slow the progressive rate of aging, is to be featured as a national sponsor on the PBS television series, Healing Quest. The show, which is the only national television series focused entirely on the latest in integrative health and natural approaches to total well-being, is launching its fourth season on PBS, and will feature LifeVantage Corporation (OTCBB: LFVN), www.lifevantage.com maker of Protandim® as one of the new sponsors. more
Thursday, February 14, 2008 LifeVantage Corporation Announces Major Expansion Into Asia, Citing Immediate Opportunities in Booming Integrative Health Market LifeVantage Corporation Announces a Marketing and Licensing Agreement With Industry Leader Nutranomics to Significantly Expand Global Distribution of Protandim(R) GREENWOOD VILLAGE, Colo., Feb 14, 2008 (BUSINESS WIRE) -- A LifeVantage Corporation (LFVN: LFVN) milestone was reached today, announced CEO David Brown, with the news that a marketing and licensing agreement has been signed with NutraNomics for the representation and distribution of Protandim(R) into the multi-billion dollar Asian market. more
Thursday, February 14, 2008 LifeVantage Corporation Announces 2Q FY 2008 Financial and Operating Results LifeVantage Corporation (OTCBB: LFVN), http://www.lifevantage.com, maker of Protandim®, today announced results for its second quarter ended December 31, 2007. For the three month period ended December 31, 2007, the Company recorded net revenues of $0.8 million and a loss of $(0.4) million, or $(0.02) per share. For the three month period ended December 31, 2006, the Company recorded net revenues of $1.1 million and a loss of $(1.8) million, or $(0.08) per share. more

Wednesday, November 19, 2008

New Study Proves Protandim® Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor

Results of a new peer-reviewed study published online in the journal Free Radical Biology and Medicine clearly demonstrates that the synergistic impact of the active ingredients used in the formulation of Protandim® dramatically increases the body's production of glutathione, a key antioxidant and anti-aging factor, as well as increases important antioxidant enzymes. more

Tuesday, November 18, 2008

LifeVantage Corporation Announces 1Q FY 2009 Financial and Operating Results

LifeVantage Corporation (OTCBB: LFVN), maker of Protandim®, today announced results for its first quarter ended September 30, 2008. For the three month period ended September 30, 2008, the Company recorded net revenues of $1.3 million, which includes $0.5 million of previously deferred revenue, and a loss of $(0.1) million, or $(0.01) per share. For the three month period ended September 30, 2007, the Company recorded net revenues of $0.8 million and a loss of $(0.3) million, or $(0.01) per share. more

Wednesday, October 29, 2008

LifeVantage Announces Launch of Protandim(R) Into Multi-Billion Dollar Network Marketing Sales Channel

Protandim® (www.Protandim.com), the only product clinically proven to slow the progressive rate of aging, announced today that it is entering the multi-billion dollar network marketing industry via independent distributorships offered by the product's maker, LifeVantage Corporation (OTCBB:LFVN). The company will continue to have a retail presence, in addition to the independent distributorships. more

Wednesday, October 08, 2008

Carlon M. Colker, M.D., FACN, Nationally Renowned Medical Expert in the Areas of Wellness, Physical Performance and Performance Nutrition, Joins LifeVantage Corporation Scientific Advisory Board

LifeVantage Corporation (OTCBB:LFVN),the maker ofProtandim®, the only product clinically proven to slow the progressive rate of aging, today announced that nationally renowned wellness expert, Carlon Colker, M.D., FACN, has joined the Company's Scientific Advisory Board. Dr. Colker is the CEO and Medical Director of Peak Wellness, Inc., and is widely recognized as America's premier wellness advisor. He is well-known for his work with marquee athletes and for his many books and articles on various health and wellness issues. Dr. Colker is a regular medical correspondent on Fox News Channel and, as Shaquille O'Neal's physician, recently co-starred with O'Neal on ABC's "Shaq's Big Challenge", to fight childhood obesity. more

Wednesday, October 01, 2008

LifeVantage Corporation Schedules 4th Quarter and FY 2008 Conference Call

SAN DIEGO--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB LFVN - News), maker of Protandim®, will hold a conference call on October 7, 2008 at 10:00 a.m. PT (1:00 p.m. ET) to discuss its fourth quarter and fiscal year 2008 financial and operating results. more

Tuesday, September 23, 2008

LifeVantage Corporation Announces Q4 and FY 2008 Financial and Operating Results

SAN DIEGO--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB: LFVN- News), maker of Protandim®, today announced results for its year ended June 30, 2008. The Company recorded net revenues of $3.2 million and a net loss of $(2.1) million, or $(0.09) per share, for its year ended June 30, 2008. For its year ended June 30, 2007, the Company reported net revenues of $5.1 million and a net loss of $(3.7) million, or $(0.17) per share. more

Thursday, September 04, 2008

LifeVantage Corporation Invited to Present at EdgeWater Research Small/Micro Cap Conference September 24th and 25th, 2008

LifeVantage Corporation (OTCBB: LFVN), the maker ofProtandim®, the only product clinically proven to slow the progressive rate of aging, today announced that the senior management team has been invited to present at the upcoming EdgeWater Research Fall 2008 Small/Micro Cap Conference to be held in Coeur d' Alene, Idaho, on September 24th and 25th, 2008. more

Thursday, August 21, 2008

LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs

LifeVantage Corporation(OTCBB:LFVN), the maker of Protandim®, the only product clinically proven to slow the progressive rate of aging, announced the company has joined forces with Cornerstone Research and Development, Inc., a leading manufacturer owned by Mitsui USA, to dramatically cut product manufacturing costs. more

Thursday, August 14, 2008

LifeVantage Corporation Posts Record Unique Visitors & Page Views for Protandim.com

LifeVantage Corporation (OTCBB: LFVN),the maker of Protandim®, the only product clinically proven to slow the progressive rate of aging, announced today that Protandim.com had over 60,000 unique visitors to the website in July 2008, with over 170,000 page views, far exceeding historical levels. The company also reported that this increase in web traffic resulted in the highest number of new Internet customer acquisitions in nearly three years. more

Wednesday, August 13, 2008

LifeVantage Corporation Announces Increased Sales Distribution for Protandim(R)

LifeVantage Corporation (OTCBB: LFVN) has announced it has increased distribution of Protandim® (www.protandim.com) via a network of well-known regional brokers; the initiation of a direct sales program to healthcare professionals; and a partnership providing an entree into the fitness arena. more

Wednesday, June 18, 2008

'Super-Antioxidant' Study to Examine Relationship between Anti-Aging and Skin's Natural Ability to Rejuvenate at the Cellular Level

A new "Super-Antioxidant" study hopes to prove that the fountain of youth is on the horizon, thanks to advances in anti-aging that are attributed to regenerating skin at the cellular level. A team of researchers, led by Dr. Kimberly Stone, M.D., a leading Denver-based board certified dermatologist, are studying a blend of Protandim® (which has been clinically proven to slow the progressive rate of aging www.protandim.com) and LP Derma Complex (shown to effectively reduce the appearance of wrinkles and other effects of aging upon the skin) to determine if a topical cream made of these combined ingredients will play a pivotal role in providing proven methods to age gracefully. more

Monday, March 10, 2008

LifeVantage Expands Global Marketing Initiatives with the Addition of Key Industry Strategists Jan Strode and Peter Baloff

LifeVantage Corporation (OTCBB: LFVN) announces that Jan Strode, prominent industry expert, advisor and strategist to companies ranging from start-ups to Fortune 100 companies on the topics of marketing, communications and sales, and Peter Baloff, nationally recognized creative consultant, have joined forces with LifeVantage, the maker of Protandim (www.protandim.com) to spearhead creative, marketing, and national public relations efforts. Protandim is the patented nutritional supplement that is clinically proven to slow the progressive rate of aging by increasing the body's natural antioxidant protection at the cellular level. more

Wednesday, March 05, 2008

LifeVantage Corporation Schedules 2nd Quarter FY 2008 Conference Call

LifeVantage Corporation (OTCBB: LFVN), formerly Lifeline Therapeutics, Inc., maker of Protandim®, will hold a conference call on Tuesday, March 11, 2008 at 9:00 a.m. MT (11:00 a.m. ET) to introduce its new CEO David Brown, discuss its second quarter fiscal year 2008 financial and operating results, and remind investors of upcoming warrant expiration dates and repricing opportunities. Mr. Brown's presentation will be available on Monday, March 10, 2008 via the Company's website. more

Tuesday, February 19, 2008

Clinically Proven to Slow the Progressive Rate of Aging, Protandim(R), is Featured as a National Sponsor on PBS Series 'Healing Quest'

Protandim(www.protandim.com) the patented nutritional supplement which is clinically proven to slow the progressive rate of aging, is to be featured as a national sponsor on the PBS television series, Healing Quest. The show, which is the only national television series focused entirely on the latest in integrative health and natural approaches to total well-being, is launching its fourth season on PBS, and will feature LifeVantage Corporation (OTCBB: LFVN), www.lifevantage.com maker of Protandim® as one of the new sponsors. more

Thursday, February 14, 2008

LifeVantage Corporation Announces Major Expansion Into Asia, Citing Immediate Opportunities in Booming Integrative Health Market

LifeVantage Corporation Announces a Marketing and Licensing Agreement With Industry Leader Nutranomics to Significantly Expand Global Distribution of Protandim(R) GREENWOOD VILLAGE, Colo., Feb 14, 2008 (BUSINESS WIRE) -- A LifeVantage Corporation (LFVN: LFVN) milestone was reached today, announced CEO David Brown, with the news that a marketing and licensing agreement has been signed with NutraNomics for the representation and distribution of Protandim(R) into the multi-billion dollar Asian market. more

Thursday, February 14, 2008

LifeVantage Corporation Announces 2Q FY 2008 Financial and Operating Results

LifeVantage Corporation (OTCBB: LFVN), http://www.lifevantage.com, maker of Protandim®, today announced results for its second quarter ended December 31, 2007. For the three month period ended December 31, 2007, the Company recorded net revenues of $0.8 million and a loss of $(0.4) million, or $(0.02) per share. For the three month period ended December 31, 2006, the Company recorded net revenues of $1.1 million and a loss of $(1.8) million, or $(0.08) per share. more

2009

2008

NEWS

COMPANY HEADLINES

Company